Dr. Melvin Weinstein Becomes a Member of First Light Diagnostics Clinical Advisory Board
Chelmsford, MA (November 13, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Melvin P. Weinstein, M.D., to the company’s world-class, international Clinical Advisory Board. “Dr. Weinstein is a recognized expert in infectious disease and antimicrobial susceptibility testing…
First Light Joins Global Initiative to Combat Antibiotic Resistance
Commits to deliver platform to enable targeted treatment at the onset of infection First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced their participation in the U.S. Centers for Disease Control and Prevention (CDC) Antimicrobial Resistance (AMR) Challenge. First Light’s MultiPath™ platform will…
David Macdonald to Present at BIO Investor Forum
Two-day event highlights investment trends and opportunities in Life Sciences Chelmsford, MA (October 16, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced that First Light’s President & CEO, David Macdonald will be among the presenters at the 2019 BIO Investor…
Dr. Angela Caliendo Joins First Light Diagnostics Clinical Advisory Board
Chelmsford, MA (October 9, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Angela M. Caliendo, M.D., Ph.D., to the company’s world-class, international Clinical Advisory Board. “Angie’s expertise and deep research experience in the development of diagnostic tests…
Dr. Joanne Spadoro Joins First Light Diagnostics
New Senior VP of R&D and Regulatory Affairs will help guide product development and regulatory clearance. Chelmsford, MA, September 25, 2019 – First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced the addition of Dr. Joanne Spadoro as its Vice…
First Light Diagnostics MultiPath™ Part of Innovation Alley at IDWeek 2019
Chelmsford, MA, September 5, 2019 – First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced their participation at IDWeek 2019 from October 2 – 6 in Washington, DC. First Light Diagnostics will be exhibiting at booth 445. Representatives will be available…
First Light Diagnostics MultiPath™ Platform to be Showcased at AACC 2019
CHELMSFORD, Mass., July 31, 2019 (Newswire.com) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced their participation at the American Association for Clinical Chemistry’s (AACC) 71st Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California from August 4-8. First Light Diagnostics will…
First Light Diagnostics Receives Technology Innovation Leader Award at Frost & Sullivan Gala
Chelmsford, MA – (July 24th, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, formally received their award for Technology Innovation at the 2019 Frost & Sullivan Excellence in Best Practices Awards Gala on July 17th at the San Diego Marriott La Jolla,…
First Light Adds New Multimedia to Website
New videos include 1-1 clinician interviews and detailed product tour Chelmsford, MA – (July 10th, 2019) First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the introduction of new multimedia content on the homepage of the First Light Diagnostics website. The new content…
First Light Diagnostics Announces Closing of a $4.5 million Debt Financing
Additional funds to support the company’s diagnostic platform initiatives Chelmsford, MA – (June 19, 2019) – First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced the closing of a $4.5 million debt financing. This includes a Lease Line with CSC…